API under development

     PRODUCTS

  • Apremilast
  • Canagliflozin
  • Dapagliflozin
  • Edoxaban
  • Indacaterol
  • Macitentan
  • Sacubitril / Valsartan
  • Selexipag
  • Trelagliptin

 

    ONCOLOGY

  • Tofacitinib

None of the products will be offered / supplied to countries in which this could be in conflict with existing patents. 

Patented products available for R & D use as permitted under 35 USC 271 (e) (1). 

Cobapharma API Under Development.pdf
Documento Adobe Acrobat [88.2 KB]